| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:464878601:3018 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:464878601:3018?format=raw |
LEADER: 03018cam a2200541 a 4500
001 3918114
005 20221027001520.0
008 850920m19851986dcu b 001 0 eng
010 $a 84062037
020 $a0309034949 (pbk. : v. 1)
020 $a0309036798 (pbk. : v. 2)
035 $a(OCoLC)11667096
035 $a(OCoLC)ocm11667096
035 $a(CStRLIN)NYCM85-B4191
035 $9ADH0483HS
035 $a(NNC)3918114
035 $a3918114
040 $dNNC-M
043 $an-us---$ad------
050 00 $aRA638$b.N49 1985
082 0 $a614.4/7/0973$219
245 00 $aNew vaccine development :$bestablishing priorities /$cby the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention [and] Division of International Health, Institute of Medicine.
260 $aWashington, D.C. :$bNational Academy Press,$c1985-1986.
300 $a2 volumes ;$c28 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aPrepared for the National Institute of Allergy and Infectious Diseases.
500 $aVol. 2 has statement of responsibility: by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention and Division of International Health, Institute of Medicine.
504 $aIncludes bibliographies and indexes.
505 0 $av. 1. Diseases of importance in the United States -- v. 2. Diseases of importance in developing countries.
650 0 $aVaccines$xResearch$xGovernment policy.
650 0 $aVaccination$zUnited States.$0http://id.loc.gov/authorities/subjects/sh2010117637
650 0 $aVaccination$zDeveloping countries.
650 2 $aVaccines$xsupply & distribution.$0https://id.nlm.nih.gov/mesh/D014612Q000600
650 2 $aVaccines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014612Q000627
650 2 $aDeveloping Countries$xtrends.
650 2 $aHealth Priorities.$0https://id.nlm.nih.gov/mesh/D006292
650 2 $aDiarrhea$xprevention & control.$0https://id.nlm.nih.gov/mesh/D003967Q000517
650 2 $aHaemophilus.$0https://id.nlm.nih.gov/mesh/D006190
650 2 $aHepatitis$xprevention & control.$0https://id.nlm.nih.gov/mesh/D006505Q000517
650 2 $aCommunicable Disease Control.$0https://id.nlm.nih.gov/mesh/D003140
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
710 2 $aInstitute of Medicine (U.S.).$bCommittee on Issues and Priorities for New Vaccine Development.$0http://id.loc.gov/authorities/names/n84201079
710 2 $aNational Institute of Allergy and Infectious Diseases (U.S.)$0http://id.loc.gov/authorities/names/n79084679
710 2 $aInstitute of Medicine (U.S.).$bDivision of Health Promotion and Disease Prevention.$0http://id.loc.gov/authorities/names/n80156868
710 2 $aInstitute of Medicine (U.S.).$bDivision of International Health.$0http://id.loc.gov/authorities/names/n80033574
852 01 $boff,hsl$hRA638$i.N49 1985
866 30 $80$av. 1-2